β-cell Jagged1 is sufficient but not necessary for islet Notch activity and insulin secretory defects in obese mice

Objective: Notch signaling, re-activated in β cells from obese mice and causal to β cell dysfunction, is determined in part by transmembrane ligand availability in a neighboring cell. We hypothesized that β cell expression of Jagged1 determines the maladaptive Notch response and resultant insulin se...

Full description

Bibliographic Details
Main Authors: Nina Suda, Alberto Bartolomé, Jiani Liang, Jinsook Son, Yoko Yagishita, Christian Siebel, Domenico Accili, Hongxu Ding, Utpal B. Pajvani
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Molecular Metabolism
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2212877824000255
_version_ 1797272476643753984
author Nina Suda
Alberto Bartolomé
Jiani Liang
Jinsook Son
Yoko Yagishita
Christian Siebel
Domenico Accili
Hongxu Ding
Utpal B. Pajvani
author_facet Nina Suda
Alberto Bartolomé
Jiani Liang
Jinsook Son
Yoko Yagishita
Christian Siebel
Domenico Accili
Hongxu Ding
Utpal B. Pajvani
author_sort Nina Suda
collection DOAJ
description Objective: Notch signaling, re-activated in β cells from obese mice and causal to β cell dysfunction, is determined in part by transmembrane ligand availability in a neighboring cell. We hypothesized that β cell expression of Jagged1 determines the maladaptive Notch response and resultant insulin secretory defects in obese mice. Methods: We assessed expression of Notch pathway components in high-fat diet-fed (HFD) or leptin receptor-deficient (db/db) mice, and performed single-cell RNA sequencing (scRNA-Seq) in islets from patients with and without type 2 diabetes (T2D). We generated and performed glucose tolerance testing in inducible, β cell-specific Jagged1 gain-of- and loss-of-function mice. We also tested effects of monoclonal neutralizing antibodies to Jagged1 in glucose-stimulated insulin secretion (GSIS) assays in isolated islets. Results: Jag1 was the only Notch ligand that tracked with increased Notch activity in HFD-fed and db/db mice, as well as in metabolically-inflexible β cells enriched in patients with T2D. Neutralizing antibodies to block Jagged1 in islets isolated from HFD-fed and db/db mice potentiated GSIS ex vivo. To demonstrate if β cell Jagged1 is sufficient to cause glucose tolerance in vivo, we generated inducible β cell-specific Jag1 transgenic (β-Jag1TG) and loss-of-function (iβ-Jag1KO) mice. While forced Jagged1 impaired glucose intolerance due to reduced GSIS, loss of β cell Jagged1 did not protect against HFD-induced insulin secretory defects. Conclusions: Jagged1 is increased in islets from obese mice and in patients with T2D, and neutralizing Jagged1 antibodies lead to improved GSIS, suggesting that inhibition of Jagged1-Notch signaling may have therapeutic benefit. However, genetic loss-of-function experiments suggest that β cells are not a likely source of the Jagged1 signal.
first_indexed 2024-03-07T14:28:54Z
format Article
id doaj.art-3e7e5ec93dc1485189fc1b20f33fec79
institution Directory Open Access Journal
issn 2212-8778
language English
last_indexed 2024-03-07T14:28:54Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Molecular Metabolism
spelling doaj.art-3e7e5ec93dc1485189fc1b20f33fec792024-03-06T05:26:41ZengElsevierMolecular Metabolism2212-87782024-03-0181101894β-cell Jagged1 is sufficient but not necessary for islet Notch activity and insulin secretory defects in obese miceNina Suda0Alberto Bartolomé1Jiani Liang2Jinsook Son3Yoko Yagishita4Christian Siebel5Domenico Accili6Hongxu Ding7Utpal B. Pajvani8Department of Medicine, Columbia University, New York, NY, USADepartment of Medicine, Columbia University, New York, NY, USADepartment of Medicine, Columbia University, New York, NY, USADepartment of Medicine, Columbia University, New York, NY, USADepartment of Medicine, Columbia University, New York, NY, USADepartment of Discovery Oncology, Genentech, South San Francisco, CA, USADepartment of Medicine, Columbia University, New York, NY, USADepartment of Pharmacy Practice & Science, College of Pharmacy, University of Arizona, Tucson, AZ, 85721, USADepartment of Medicine, Columbia University, New York, NY, USA; Corresponding author. Columbia University Medical Center, Russ Berrie Science Pavilion, 1150 St, Nicholas Avenue, New York, NY 10032, USA.Objective: Notch signaling, re-activated in β cells from obese mice and causal to β cell dysfunction, is determined in part by transmembrane ligand availability in a neighboring cell. We hypothesized that β cell expression of Jagged1 determines the maladaptive Notch response and resultant insulin secretory defects in obese mice. Methods: We assessed expression of Notch pathway components in high-fat diet-fed (HFD) or leptin receptor-deficient (db/db) mice, and performed single-cell RNA sequencing (scRNA-Seq) in islets from patients with and without type 2 diabetes (T2D). We generated and performed glucose tolerance testing in inducible, β cell-specific Jagged1 gain-of- and loss-of-function mice. We also tested effects of monoclonal neutralizing antibodies to Jagged1 in glucose-stimulated insulin secretion (GSIS) assays in isolated islets. Results: Jag1 was the only Notch ligand that tracked with increased Notch activity in HFD-fed and db/db mice, as well as in metabolically-inflexible β cells enriched in patients with T2D. Neutralizing antibodies to block Jagged1 in islets isolated from HFD-fed and db/db mice potentiated GSIS ex vivo. To demonstrate if β cell Jagged1 is sufficient to cause glucose tolerance in vivo, we generated inducible β cell-specific Jag1 transgenic (β-Jag1TG) and loss-of-function (iβ-Jag1KO) mice. While forced Jagged1 impaired glucose intolerance due to reduced GSIS, loss of β cell Jagged1 did not protect against HFD-induced insulin secretory defects. Conclusions: Jagged1 is increased in islets from obese mice and in patients with T2D, and neutralizing Jagged1 antibodies lead to improved GSIS, suggesting that inhibition of Jagged1-Notch signaling may have therapeutic benefit. However, genetic loss-of-function experiments suggest that β cells are not a likely source of the Jagged1 signal.http://www.sciencedirect.com/science/article/pii/S2212877824000255NotchJagged1Beta cellAlpha cellInsulin secretionDiabetes
spellingShingle Nina Suda
Alberto Bartolomé
Jiani Liang
Jinsook Son
Yoko Yagishita
Christian Siebel
Domenico Accili
Hongxu Ding
Utpal B. Pajvani
β-cell Jagged1 is sufficient but not necessary for islet Notch activity and insulin secretory defects in obese mice
Molecular Metabolism
Notch
Jagged1
Beta cell
Alpha cell
Insulin secretion
Diabetes
title β-cell Jagged1 is sufficient but not necessary for islet Notch activity and insulin secretory defects in obese mice
title_full β-cell Jagged1 is sufficient but not necessary for islet Notch activity and insulin secretory defects in obese mice
title_fullStr β-cell Jagged1 is sufficient but not necessary for islet Notch activity and insulin secretory defects in obese mice
title_full_unstemmed β-cell Jagged1 is sufficient but not necessary for islet Notch activity and insulin secretory defects in obese mice
title_short β-cell Jagged1 is sufficient but not necessary for islet Notch activity and insulin secretory defects in obese mice
title_sort β cell jagged1 is sufficient but not necessary for islet notch activity and insulin secretory defects in obese mice
topic Notch
Jagged1
Beta cell
Alpha cell
Insulin secretion
Diabetes
url http://www.sciencedirect.com/science/article/pii/S2212877824000255
work_keys_str_mv AT ninasuda bcelljagged1issufficientbutnotnecessaryforisletnotchactivityandinsulinsecretorydefectsinobesemice
AT albertobartolome bcelljagged1issufficientbutnotnecessaryforisletnotchactivityandinsulinsecretorydefectsinobesemice
AT jianiliang bcelljagged1issufficientbutnotnecessaryforisletnotchactivityandinsulinsecretorydefectsinobesemice
AT jinsookson bcelljagged1issufficientbutnotnecessaryforisletnotchactivityandinsulinsecretorydefectsinobesemice
AT yokoyagishita bcelljagged1issufficientbutnotnecessaryforisletnotchactivityandinsulinsecretorydefectsinobesemice
AT christiansiebel bcelljagged1issufficientbutnotnecessaryforisletnotchactivityandinsulinsecretorydefectsinobesemice
AT domenicoaccili bcelljagged1issufficientbutnotnecessaryforisletnotchactivityandinsulinsecretorydefectsinobesemice
AT hongxuding bcelljagged1issufficientbutnotnecessaryforisletnotchactivityandinsulinsecretorydefectsinobesemice
AT utpalbpajvani bcelljagged1issufficientbutnotnecessaryforisletnotchactivityandinsulinsecretorydefectsinobesemice